UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023453
Receipt number R000027004
Scientific Title Clinical Studies of mechanism on oral tolerance induction by slow oral immunothrapy
Date of disclosure of the study information 2016/08/13
Last modified on 2020/08/08 16:32:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Studies of mechanism on oral tolerance induction by slow oral immunothrapy

Acronym

Clinical Studies on oral tolerance induction by slow oral immunothrapy

Scientific Title

Clinical Studies of mechanism on oral tolerance induction by slow oral immunothrapy

Scientific Title:Acronym

Clinical Studies on oral tolerance induction by slow oral immunothrapy

Region

Japan


Condition

Condition

Food allergy

Classification by specialty

Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reveal mechanism of oral tolerance induction

Basic objectives2

Others

Basic objectives -Others

validation of the difference of immunoglobulin dynamics between Successful and non-successful

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Validation of Salava specific IgA for three years

Key secondary outcomes

Validation of Serum specific IgE for three years


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

allergen foods are slowly increasing to the target amount and continuing its amount until tolerance induction.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

food allergy patients who wish to join this study at the age of five or more.

Key exclusion criteria

1; Patients using beta-blockers, 2; patients who are pregnant at the time of the start of treatment, 3; Patient who has the unstable severe asthma, 4; Patients with systemically serious disease (malignant tumors, autoimmune diseases, immune deficiencies, severe heart disease, chronic infections, etc.), 5; patients using continuous use systemic corticosteroids or anti-cancer agents, and 6; Patients who are suffering from acute infection.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yasuto
Middle name
Last name Kondo

Organization

Fujita Health University, Second teaching Hospital

Division name

Department of Pediatrics, School of Medicine

Zip code

454-8509

Address

3-6-10, Otoubashi, Nakagawa, Nagoya

TEL

052-323-5649

Email

ykondo@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Yasuto
Middle name
Last name Kondo

Organization

Fujita Health University, Second teaching Hospital

Division name

Department of Pediatrics

Zip code

454-8509

Address

3-6-10, Otoubashi, Nakagawa, Nagoya

TEL

052-323-5649

Homepage URL


Email

ykondo@fujita-hu.ac.jp


Sponsor or person

Institute

Department of Pediatrics, School of Medicine, Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Department of Pediatrics, School of Medicine, Fujita Health University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kyoto College of Nutritional & Medical Sciences

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health Uninersity

Address

1-98 Dengakugakubo Kutsukake, Toyoake, Aichi, Japan

Tel

0562-93-2865

Email

irb-sys@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 04 Month 08 Day

Date of IRB

2020 Year 07 Month 04 Day

Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 02 Day

Last modified on

2020 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027004


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name